Global Medical REIT Inc. (NYSE:XRN) Receives Consensus Rating of “Hold” from Analysts

Posted by on Sep 18th, 2026

Global Medical REIT Inc. (NYSE:XRN – Get Free Report) has been assigned an average recommendation of “Hold” from the nine analysts that are presently covering the company, Marketbeat.com reports. Seven analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $39.60.

Several brokerages recently weighed in on XRN. Zacks Research upgraded shares of Global Medical REIT to a “hold” rating in a report on Wednesday, July 22nd. Wall Street Zen raised Global Medical REIT from a “sell” rating to a “hold” rating in a report on Saturday, September 12th. Huntington started coverage on Global Medical REIT in a report on Thursday, September 10th. They issued a “market perform” rating and a $37.00 price objective on the stock. Weiss Ratings upgraded Global Medical REIT from a “sell (d+)” rating to a “hold (c)” rating in a research report on Thursday, August 13th. Finally, BMO Capital Markets boosted their price target on shares of Global Medical REIT from $39.00 to $40.00 and gave the company a “market perform” rating in a research report on Monday, July 13th.

Read Our Latest Research Report on XRN

Insiders Place Their Bets

In other news, CEO Mark Okey Decker, Jr. purchased 8,000 shares of the stock in a transaction dated Monday, August 10th. The stock was acquired at an average cost of $35.88 per share, for a total transaction of $287,040.00. Following the completion of the transaction, the chief executive officer directly owned 67,774 shares in the company, valued at approximately $2,431,731.12. This represents a 13.38% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Also, COO Aaron Roseth bought 13,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 12th. The shares were purchased at an average cost of $36.73 per share, for a total transaction of $495,855.00. Following the purchase, the chief operating officer owned 13,500 shares in the company, valued at $495,855. This represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased a total of 71,525 shares of company stock valued at $2,579,304 over the last 90 days. 8.90% of the stock is owned by company insiders.

Hedge Funds Weigh In On Global Medical REIT

Institutional investors have recently modified their holdings of the business. Heartland Advisors Inc. raised its position in Global Medical REIT by 177.4% in the 4th quarter. Heartland Advisors Inc. now owns 423,460 shares of the company’s stock valued at $14,288,000 after purchasing an additional 270,786 shares in the last quarter. Arrow Investment Advisors LLC increased its holdings in Global Medical REIT by 339.7% in the fourth quarter. Arrow Investment Advisors LLC now owns 28,028 shares of the company’s stock valued at $946,000 after buying an additional 21,654 shares during the last quarter. Nomura Asset Management Co. Ltd. lifted its holdings in Global Medical REIT by 11.4% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 19,600 shares of the company’s stock worth $661,000 after buying an additional 2,000 shares during the last quarter. Clifford Capital Partners LLC boosted its position in shares of Global Medical REIT by 31.3% during the 4th quarter. Clifford Capital Partners LLC now owns 14,694 shares of the company’s stock worth $496,000 after acquiring an additional 3,504 shares in the last quarter. Finally, Eurizon Capital SGR S.p.A. purchased a new position in shares of Global Medical REIT in the 4th quarter valued at about $92,000. Institutional investors and hedge funds own 57.52% of the company’s stock.

Global Medical REIT Trading Up 1.3%

NYSE:XRN opened at $36.08 on Friday. The company has a quick ratio of 0.59, a current ratio of 0.59 and a debt-to-equity ratio of 1.37. The stock has a market capitalization of $477.70 million, a price-to-earnings ratio of 9.70 and a beta of 1.10. Global Medical REIT has a 52 week low of $29.05 and a 52 week high of $39.93. The firm has a 50 day moving average of $36.66 and a 200 day moving average of $35.97.

Global Medical REIT (NYSE:XRN – Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $4.78 earnings per share for the quarter, topping the consensus estimate of $0.83 by $3.95. The business had revenue of $39.75 million during the quarter. Global Medical REIT had a return on equity of 13.31% and a net margin of 36.82%. As a group, sell-side analysts anticipate that Global Medical REIT will post 2.89 earnings per share for the current fiscal year.

Global Medical REIT Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Friday, December 18th. Stockholders of record on Friday, November 20th will be paid a $0.16 dividend. This represents a c) annualized dividend and a dividend yield of 5.3%. The ex-dividend date of this dividend is Friday, November 20th. Global Medical REIT’s dividend payout ratio is 51.61%.

About Global Medical REIT

(Get Free Report)

Global Medical REIT Inc is a healthcare-focused real estate investment trust that acquires, owns and manages medical office buildings and other healthcare-related properties. Its portfolio has primarily included outpatient facilities leased to physician groups, specialty medical providers and healthcare systems.

The company generally operates under long-term, often triple-net leases, under which tenants are responsible for many property-level expenses such as taxes, insurance and maintenance.

Featured Stories

Analyst Recommendations for Global Medical REIT (NYSE:XRN)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.